![Rémi Delansorne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd.
Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Former positions of Rémi Delansorne
Companies | Position | End |
---|---|---|
ATON | Chief Executive Officer | 12/03/2020 |
Merck Serono Ltd.
![]() Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Training of Rémi Delansorne
École Nationale Vétérinaire d'Alfort | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ATON | Health Technology |
Private companies | 2 |
---|---|
Merck Serono Ltd.
![]() Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Université Pierre et Marie Curie | Consumer Services |
- Stock Market
- Insiders
- Rémi Delansorne